Gastrin Hormone Market Outlook:
Gastrin Hormone Market size was valued at USD 943.69 million in 2025 and is expected to reach USD 1.58 billion by 2035, expanding at around 5.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of gastrin hormone is assessed at USD 988.7 million.
The major reason for the global market growth during the forecast period is the rising cases of digestive disorders among the global population. As gastrin hormone stimulates the release of gastric acid, it plays an imperative role in the digestive process which has the ability to break down the proteins in the food that is consumed. Thus, with the rising cases of digestive disorders cases, the need for effective gastrin hormone is raised for bringing the digestion process back to normal. According to data found in a survey, it was found that in 2020, digestive diseases affected almost 60 million to 70 million people, which caused around 4 million hospitalizations, 70 million ambulatory-care visits, and 240,000 deaths in the North American region.
Gastrin hormones are effective medical products that are considered to be high-quality hormones that are produced by the wall of the pyloric end of the stomach in humans. It is highly effective in digestion processes and is responsible for enhancing gastric mucosal growth, gastric motility, and secretion of hydrochloric acid (HCI) into the stomach. The global gastrin hormone market is estimated to foresee tremendous growth owing to the increasing digestion-related diseases, obesity due to improper digestion, and deficiency of gastrin hormone in the body. Furthermore, gut infections along with illnesses occurring in the stomach are other factors that are anticipated to bring favorable opportunities for the expansion of the market during the forecast period.
